Global Lipid Nanoparticle Drug Delivery Market Size, Share, Analysis By Payload Type (mRNA & saRNA Delivery, siRNA & Oligonucleotide Delivery, Gene Editing & CRISPR Cargo Delivery, Small Molecule and Protein Payloads), By Application (Infectious Disease Vaccines, Genetic & Liver Diseases, Oncology, Rare & Metabolic Diseases), By End User (Pharmaceutical & Biotechnology Companies, CDMOs & Manufacturing Partners, Academic Research Institutes), By Business Model (Commercial LNP Products, Licensed IP Platforms, Development & Manufacturing Services) Industry Trends, Competitive Landscape & Forecast 2026–2034